2 completed, 1 recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Insulin Aspart Injection: new trials by email Literature Review of Insulin Aspart Injection trials Research Report on Insulin Aspart Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of GZR101-80 Injection With Separately Injected, Simultaneous Doses of GZR33 Injection and Insulin Aspart GZR101 80 Injection, GZR33 Injection, Insulin Aspart Injection - Healthy Participants | Phase 1 | Recruiting | Gan & Lee Pharmaceuticals. | 26 | 2026-11-02 | 2026-11-17 |
| Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM Insulin Degludec and Insulin Aspart Injection, Insulin Aspart Injection - Type 2 Diabetes Mellitus | Not applicable | Completed | Beijing Hospital | 218 | 2023-03-23 | 2025-12-03 |
| A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety insulin Aspart injection, insulin Aspart injection (NovoRapid) - Diabetes | Phase 3 | Completed | Tonghua Dongbao Pharmaceutical Co.,Ltd | 563 | 2015-06-19 | 2023-12-22 |
Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1)
Beijing Hospital (1) · Gan & Lee Pharmaceuticals. (1) · Tonghua Dongbao Pharmaceutical Co.,Ltd (1)
China (3)
WP Jia (1)